<DOC>
	<DOCNO>NCT00306332</DOCNO>
	<brief_summary>T-cell B-cell depletion allogeneic peripheral blood stem cell transplantation use immunomagnetic negative positive selection procedure Background : Removal T-cells donor graft ( T-cell depletion ) offer possibility prevention GVHD subsequently less transplant related morbidity mortality allogeneic stem cell transplantation ( SCT ) . There several technique deplete T-cells stem cell graft e.g . physical , immunological combine physical / immunological separation method . All technique result stem cell graft sufficient CD34+ stem cell combine adequate depletion T B cell . CD34+ select stem cell graft pure contain additional cell population . In contrast , CD3+/CD19+ deplete graft still contain NK-cells , monocytes dendritic cell part innate immune system . Theoretically , presence cell may positively influence immunological reconstitution graft-versus-leukaemia ( GVL ) effect , respectively , result improve outcome SCT Objectives : To evaluate difference immunological reconstitution , transplant related mortality , disease-free survival overall survival T-cell deplete allogeneic SCT haematological malignancy use either immunomagnetic CD34+ selection immunomagnetic CD3+/CD19+ depletion use CliniMACS system approximately 270 consecutive patient . Additionally study 20 consecutive patient kinetics NK-cel reconstitution difference NK-cell repertoire monitor . NK-cell mediate anti-tumor reactivity monitor patient transplant without NK-cells stem cell graft ( CD3+/CD19+ depletion , versus CD34+ selection ) . Secondary objective evaluate clinical relevance minor histocompatibility-specific cytotoxic T-cell responses GVL effect , kinetics NK-cell reconstitution difference NK-cell repertoire use different T-cell depletion protocol . Design : Single center prospective randomise phase III study Population : Patients eligible allogeneic SCT accord standard criterion institution receive allogeneic T- B-cell deplete SCT peripheral stem cell HLA-identical sibling donor HLA-identical unrelated voluntary ( VUD ) donor . Intervention : T-cell depletion conduct use two different technique : either immunomagnetic CD34+ selection immunomagnetic CD3+/CD19+ depletion . Endpoints : Primary endpoint immunological reconstitution , relapse , disease free survival overall survival . Secondary endpoint : NK-cell reconstitution NK-cell mediate anti-tumour reactivity . Cytotoxic T-cell response GVL effect . Estimated effort risk participate patient : We n't expect extra patient effort risk T-cell depletion standard procedure clinic many year . There extensive experience immunological T-cell depletion technique . We hypothesize CD3+/CD19+ depletion favour stem cell transplant outcome . Immunological molecular biological study perform blood sample already obtain part standard protocol .</brief_summary>
	<brief_title>T-cell B-cell Depletion Allogeneic Peripheral Blood Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<criteria>Patients diagnosis : De novo acute myeloid leukaemia first second remission . Secondary acute myeloid leukaemia first second remission supervene myelodysplastic syndrome cytotoxic / immunosuppressive therapy . Acute lymphoblastic leukaemia first second remission . Myelodysplastic syndrome . Chronic myeloid leukaemia , patient candidate SCT . Malignant lymphoma follow relapse first line therapy resistant . Aggressive mantle cell lymphoma first complete remission . Age 1865 year . WHO performance 01 ( see appendix ) . Availability HLAidentical sibling HLA , A , B , DRB , DQB identical VUD donor . Life expectancy &gt; 3 month . Witnessed write informed consent . Patients severe cardiac dysfunction ( NYHAclassification IIIV ) Patients severe pulmonary dysfunction ( vital capacity diffusion &lt; 70 % predict value ) . Patients hepatic dysfunction , bilirubin transaminase &gt; 2.5 x upper normal limit Patients renal dysfunction , serum creatinin &gt; 150 umol/liter clearance &lt; 40 ml/minute . Patients history moderate ore severe CNS disturbance psychiatric problem . Prior treatment chemotherapy , immunotherapy , radiation therapy surgery within last 3 week enter study . Patients active uncontrolled infection . Patients poor medical risk non malignant systemic disease . Patients severe coagulopathy . Patients know HIV positive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Allogeneic Stem cell transplantation</keyword>
	<keyword>T-cell depletion</keyword>
	<keyword>B-cell depletion</keyword>
	<keyword>Immunomagnetic selection</keyword>
</DOC>